Article
Dietitian startup Fay has been booming from Ozempic patients and emerges from stealth with $25M from General Catalyst, Forerunner | TechCrunch
Rating:
0.0
Views:
23
Likes:
1
Library:
1
Three-way marketplace Fay matches dietitians with insurances and patients has seen increased interest from people taking Ozempic and other GLP-1s.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value